| Literature DB >> 27465116 |
Hazreen Abdul Majid1, Mohammadreza Amiri2, Nahar Mohd Azmi3, Tin Tin Su1,4, Muhammad Yazid Jalaludin5, Nabilla Al-Sadat1.
Abstract
Insufficient physical activity and growing obesity levels among Malaysian adolescents are becoming a public health concern. Our study is to identify the trends of self-reported physical activity (PA) levels, blood lipid profiles, and body composition (BC) indices from a cohort of 820 adolescents. The self-reported PA was assessed using a validated Malay version of the PA Questionnaire for Older Children (PAQ-C). Fasting blood samples were collected to investigate their lipid profiles. Height, weight, waist and hip circumferences as well as body fat percentage were measured. The baseline and the first follow-up were conducted in 2012 and 2014, respectively. A downward trend in the PA level was seen in all categories with a significant reduction among all rural adolescents (P = 0.013) and more specifically, PA among girls residing in rural areas dropped significantly (P = 0.006). Either a significant reduction in high-density lipoprotein (HDL) or a significant increment in BC indices (i.e., body mass index [BMI], waist circumference [WC], hip circumference, and body fat percentage [BF %]) were seen in this group. Female adolescents experienced more body fat increment with the reduction of physical activity. If not intervened early, adolescents from rural areas may increase their risk of developing cardiovascular diseases earlier.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27465116 PMCID: PMC4964611 DOI: 10.1038/srep30544
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Number of students in each phase of the MyHeART study.
Sample characteristics (n = 820).
| Number (%) | |
|---|---|
| Gender | |
| | 307 (37.4) |
| | 513 (62.6) |
| Ethnicity | |
| | 660 (80.5) |
| | 59 (7.2) |
| | 72 (8.8) |
| | 29 (3.5) |
| Location | |
| | 465 (56.7) |
| | 355 (43.3) |
Figure 2Physical activity level Box-Whisker plot for location by gender.
Note: Wilcoxon matched-pairs signed-ranks test of median scores difference between 2012 and 2014 reported physical activity. The ‘+’ indicates mean, asterisks indicate values of the reported physical activity in 2014 while no asterisks indicated the same values in 2012. *p < 0.05; **p < 0.01 (Note: comparisons are just with the same location by gender category).
Test of median difference between lipid profile levels in cohort (n = 820).
| 2012 | 2014 | Wilcoxon signed ranks test | |||
|---|---|---|---|---|---|
| Median (IQR | Median (IQR) | Z | |||
| 2.69 (2.25–3.16) | 2.7 (2.3–3.3) | −2.752 | |||
| 1.45 (1.27–1.69) | 1.4 (1.2–1.6) | −3.682 | |||
| 0.82 (0.61–1.08) | 0.8 (0.6–1.1) | −0.607 | |||
| 4.59 (4.1–5.16) | 4.6 (4.1–5.2) | −0.897 | |||
| 2.62 (2.18–3.07) | 2.5 (2.1–3) | −0.785 | |||
| 1.41 (1.21–1.68) | 1.3 (1.2–1.5) | −6.609 | |||
| 0.77 (0.59–1.04) | 0.8 (0.6–1.1) | −1.906 | |||
| 4.46 (4.00–5.00) | 4.3 (3.8–5) | −2.877 | |||
| 2.74 (2.32–3.25) | 2.8 (2.4–3.3) | −4.062 | |||
| 1.48 (1.30–1.70) | 1.5 (1.3–1.6) | −0.559 | |||
| 0.86 (0.62–1.10) | 0.8 (0.6–1.1) | −2.261 | |||
| 4.6 (4.17–5.20) | 4.7 (4.3–5.3) | −3.367c (p = 0.001) | |||
| 2.65 (2.22–3.13) | 2.8 (2.3–3.2) | −4.135 | |||
| 1.47 (1.3–1.64) | 1.4 (1.3–1.6) | −2.847 | |||
| 0.86 (0.64–1.13) | 0.8 (0.6–1.1) | −2.309 | |||
| 4.5 (4.10–5.10) | 4.6 (4.1–5.2) | −1.906 | |||
| 2.62 (2.12–3.05) | 2.5 (2.1–3.1) | −0.043 | |||
| 1.45 (1.30–1.60) | 1.3 (1.2–1.5) | −4.320 | |||
| 0.79 (0.62–1.08) | 0.8 (0.6–1.2) | −1.164 | |||
| 4.42 (4.10–4.94) | 4.4 (3.8–5) | −1.587 | |||
| 2.66 (2.25–3.16) | 2.8 (2.4–3.3) | −4.935 | |||
| 1.48 (1.30–1.67) | 1.5 (1.3–1.6) | −0.612 | |||
| 0.9 (0.66–1.17) | 0.8 (0.6–1.1) | −3.655 | |||
| 4.6 (4.10–5.13) | 4.7 (4.2–5.2) | −3.242 | |||
| 2.75 (2.30–3.28) | 2.7 (2.3–3.3) | −0.643 | |||
| 1.44 (1.20–1.70) | 1.4 (1.2–1.6) | −2.325 | |||
| 0.77 (0.58–1.01) | 0.8 (0.6–1.1) | −1.801 | |||
| 4.63 (4.08–5.21) | 4.5 (4–5.2) | −0.851 | |||
| 2.64 (2.20–3.10) | 2.5 (2.1–3) | −1.175 | |||
| 1.4 (1.19–1.70) | 1.3 (1.1–1.5) | −5.092 | |||
| 0.77 (0.58–1.01) | 0.8 (0.6–1.1) | −1.200 | |||
| 4.5 (3.95–5.00) | 4.3 (3.8–5) | −2.744 | |||
| 2.89 (2.42–3.40) | 2.9 (2.4–3.4) | −0.210 | |||
| 1.48 (1.23–1.70) | 1.5 (1.3–1.7) | −1.618 | |||
| 0.78 (0.58–1.03) | 0.8 (0.6–1) | −1.189 | |||
| 4.72 (4.20–5.36) | 4.8 (4.3–5.4) | −1.293 | |||
Note: 1. LDL: Low-density lipoprotein cholesterol; 2. HDL: High-density lipoprotein cholesterol; 3. TG: Triglyceride; 4. TC: Total cholesterol.
aWilcoxon Sign-ranks Test.
bBased on negative ranks.
cBased on positive ranks.
dIQR: Interquartile range.
Test of median difference between body composition indices in cohort (n = 820).
| 2012 | 2014 | Wilcoxon Signed Ranks Test | |||
|---|---|---|---|---|---|
| Median (IQR | Median (IQR) | Z | |||
| 18.54 (16.27–21.93) | 19.87 (17.72–23.65) | −19.354 | |||
| 65.75 (60.5–75) | 69 (63.7–78) | −14.063 | |||
| 84 (78–92) | 89.5 (84–96.58) | −21.919 | |||
| 21.45 (13.83–31.1) | 24.4 (16.85–32.2) | −9.335 | |||
| 18.17 (15.94–21.62) | 19.29 (17.21–23) | −10.883 | |||
| 65 (61–77) | 68.5 (63.7–80) | −9.579 | |||
| 80 (75–89) | 86.5 (81.6–95) | −13.716 | |||
| 13.3 (6.9–26.2) | 12.2 (7.5–22.5) | −3.209 | |||
| 18.76 (16.63–22.14) | 20.26 (18.02–23.93) | −16.031 | |||
| 66 (60–74) | 69 (63.55–77) | −10.465 | |||
| 86 (80–93) | 90.5 (86–98) | −17.059 | |||
| 23.7 (17.65–32.85) | 27.7 (22.8–34.5) | −13.887 | |||
| 18.61 (16.62–21.94) | 19.92 (17.86–23.38) | −14.287 | |||
| 66 (61–75) | 70 (64.7–78.9) | −10.951 | |||
| 86 (80–92.5) | 90.5 (85–97) | −16.239 | |||
| 21.9 (15.5–31.2) | 24.9 (19.3–32.2) | −7.677 | |||
| 18.57 (16.52–21.62) | 19.67 (17.44–23) | −7.426 | |||
| 68 (62–78) | 70.1 (64.7–80) | −5.793 | |||
| 83 (78–90) | 87.8 (82.6–95.7) | −9.394 | |||
| 15 (8–25.5) | 14.8 (8.7–22.4) | −2.030 | |||
| 18.67 (16.63–22.19) | 20.06 (18.03–23.67) | −12.153 | |||
| 66 (60.88–74) | 70 (64.38–78) | −9.291 | |||
| 86.25 (81–94) | 91.55 (86.5–98.05) | −13.229 | |||
| 23.3 (17.68–33.98) | 27.5 (22.68–34.33) | −10.466 | |||
| 18.41 (15.96–21.71) | 19.69 (17.43–24.12) | −14.287 | |||
| 64 (60–75) | 68.3 (62.85–76.1) | −10.951 | |||
| 81 (76–90.3) | 87.5 (82.8–96) | −16.239 | |||
| 20.7 (11.8–31.05) | 24 (11.9–32.2) | −7.677 | |||
| 17.53 (15.78–21.74) | 18.73 (17.07–23.16) | −7.745 | |||
| 64 (60–75) | 67.7 (63.2–83.8) | −7.405 | |||
| 78 (74–87) | 85.3 (81.1–92) | −9.775 | |||
| 12 (6.1–28) | 11 (6.7–24.1) | −2.606 | |||
| 18.88 (16.45–21.67) | 20.47 (17.99–24.26) | −10.465 | |||
| 65 (60–74) | 68.5 (62.2–75.5) | −4.954 | |||
| 84 (78–92) | 89.1 (84.5–97) | −10.795 | |||
| 24.3 (17.6–32.5) | 28.2 (22.9–35) | −9.171 | |||
Note: 1. BMI: Body mass index; 2. WC: Waist Circumference; 3. Hip: Hip circumference; 4. BF%: Body fat percentage.
aWilcoxon Sign-ranks Test.
bBased on negative ranks.
cBased on positive ranks.
dIQR: Interquartile range.